{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:42:37Z","timestamp":1758634957178},"reference-count":19,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T00:00:00Z","timestamp":1419984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["openmicrobiologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOMICROJ"],"published-print":{"date-parts":[[2014,12,31]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>In 2003 the outbreak of highly pathogenic H7 avian influenza occurred in the Netherlands. The avian H7 virus causing the outbreak was also detected in humans; one person died of pneumonia and acute respiratory distress syndrome. Our paper describes preclinical studies of a H7N3 live attenuated influenza A vaccine (LAIV) candidate in various animal models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives:<\/jats:title><jats:p>To study safety, immunogenicity and protection of H7N3 LAIV candidate in mice, ferrets and chickens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The vaccine was generated by a classical reassortment between low pathogenicity A\/mallard\/Netherlands\/00 (H7N3) virus and A\/Leningrad4\/17\/57 (H2N2) master donor virus (MDV).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Immunogenicity was found that H7N3 LAIV was similar to the MDV in terms of replication in the respiratory organs of mice and failed to replicate in mouse brains. One dose of a H7N3 LAIV elicited measurable antibody response and it was further boosted with a second vaccine dose. Immunization of mice with H7N3 LAIV provided protection against infection following a homologous challenge with wild type H7N3 virus. Attenuated phenotype of H7N3 LAIV has been confirmed in ferrets. Immunogenicity and protective efficacy of H7N3 LAIV in ferrets were also demonstrated. The vaccine protected animals from subsequent infection with wild type H7N3 virus. The results of histopathology study revealed that inoculation of H7N3 LAIV in ferrets did not cause any inflammation or destructive changes in lungs.<\/jats:p><jats:p>Lack of H7N3 LAIV replication in chicken demonstrated complete safety of this preparation for poultry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Results of our study suggest that new H7N3 LAIV candidate is safe, immunogenic and protects from homologues influenza virus infection in mice and ferrets.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874285801408010154","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T10:11:51Z","timestamp":1422353511000},"page":"154-162","update-policy":"http:\/\/dx.doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models"],"prefix":"10.2174","volume":"8","author":[{"given":"Andrey","family":"Rekstin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Desheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Swayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1750-2659.2008.00056.x","volume":"2","author":"Ambrose CS","year":"2008","unstructured":"Ambrose CS, Luke C, Coeling K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Respir Viruses 2008; 2 (6) : 193-202.","journal-title":"Influenza Other Respir Viruses."},{"key":"refR2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","volume":"101","author":"Fouchier RA","year":"2004","unstructured":"Fouchier RA, Schneeberger PM, Rozendaal FW , et al. Avian influenza A virus (H7N7):associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004; 101 (5) : 1356-61.","journal-title":"Proc Natl Acad Sci USA"},{"key":"refR3","first-page":"591","author":"Katz JM","year":"2008","unstructured":"Katz JM, Desheva JA, Rudenko LG, et al. Development of candidate H7N3 live attenuated influenza vaccine Proceedings of the Options for the control of influenza VI. Toronto June 17-23 2007 Int Med Press Lndon Atlanta 2008; 591-2.","journal-title":"Toronto June 17-23. 2007 Int. Med. Press Lndon Atlanta."},{"key":"refR4","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0264-410X(02)00056-7","volume":"20","author":"Wareing MD","year":"2002","unstructured":"Wareing MD, Marsh GA, Tannock GA. Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A\/Leningrad\/134\/17\/57 donor strain. Vaccine 2002; 20 (16) : 2082-90.","journal-title":"Vaccine."},{"key":"refR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0166-0934(94)00133-2","volume":"52","author":"Klimov AI","year":"1995","unstructured":"Klimov AI, Cox NJ. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods 1995; 52 (1-2) : 41-9.","journal-title":"J Virol Methods."},{"key":"refR6","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1016\/j.vaccine.2011.04.122","volume":"29","author":"Rudenko L","year":"2011","unstructured":"Rudenko L, van den Bosch H, Kiseleva I , et al. Live attenuated pandemic influenza vaccine clinical studies on A\/17\/California\/2009,\/38 (H1N1):and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. Vaccine 2011; 29 (Suppl 1 ) : A40-4.","journal-title":"Vaccine."},{"key":"refR7","first-page":"493","volume":"27","author":"Reed LJ","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27 : 493-7.","journal-title":"Am J Hyg."},{"key":"refR8","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/JVI.73.7.5903-5911.1999","volume":"73","author":"Lu X","year":"1999","unstructured":"Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1):viruses isolated from humans. J Virol 1999; 73 : 5903-11.","journal-title":"J Virol."},{"key":"refR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2002.1742","volume":"305","author":"Subbarao K","year":"2003","unstructured":"Subbarao K, Chen H, Swayne D , et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003; 305 (1) : 192-200.","journal-title":"Virology."},{"key":"refR10","unstructured":"Webster RG, Cox NJ, Stohr K. WHO manual on animal influenza diagnosis and surveillance World Health Organization, Geneva, Switzerland. http: \/\/wwwwhoint\/csr\/resources\/ publications\/influenza\/whocdscsrncs20025revpdf 2002."},{"key":"refR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-3527(09)73002-7","volume":"73","author":"Belser JA","year":"2009","unstructured":"Belser JA, Szretter KJ, Katz JM, Tumpey TM. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv Virus Res 2009; 73 : 55-97.","journal-title":"Adv Virus Res."},{"key":"refR12","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00970-07","volume":"81","author":"Joseph ?","year":"2007","unstructured":"Joseph ?, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K. Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model. J Virol 2007; 81 (19) : 10558-66.","journal-title":"J Virol."},{"key":"refR13","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1128\/JVI.00535-09","volume":"83","author":"Belser JA","year":"2009","unstructured":"Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM. Ocular infection of mice with influenza A (H7):viruses a site of primary replication and spread to the respiratory tract. J Virol 2009; 83 (14) : 7075-84.","journal-title":"J Virol."},{"key":"refR14","doi-asserted-by":"crossref","first-page":"12401","DOI":"10.1128\/JVI.79.19.12401-12407.2005","volume":"79","author":"de Wit E","year":"2005","unstructured":"de Wit E, Munster VJ, Spronken MIJ , et al. Protection mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol 2005; 79 (19) : 12401-7.","journal-title":"J Virol."},{"key":"refR15","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.vaccine.2008.01.036","volume":"26","author":"Jadhao SJ","year":"2008","unstructured":"Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y. Development of Eurasian H7N7\/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 2008; 26 (14) : 1742-50.","journal-title":"Vaccine."},{"key":"refR16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/CVI.00174-07","volume":"14","author":"Pappas C","year":"2007","unstructured":"Pappas C, Matsuoka Y, Swayne DE, Donis RO. Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Imunol 2007; 14 (11) : 1425-32.","journal-title":"Clin Vaccine Imunol"},{"key":"refR17","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01305-10","volume":"84","author":"Min JY","year":"2010","unstructured":"Min JY, Vogel L, Matsuoka Y , et al. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets and monkeys. J Virol 2010; 84 (22) : 11950-60.","journal-title":"J Virol."},{"key":"refR18","doi-asserted-by":"crossref","first-page":"e76884","DOI":"10.1371\/journal.pone.0076884","volume":"8","author":"Xu Q","year":"2013","unstructured":"Xu Q, Chen Z, Cheng X, Xu L, Jin H. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLoS One 2013; 8 (10) : e76884.","journal-title":"PLoS One."},{"key":"refR19","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2006.05.039","volume":"24","author":"Lu X","year":"2006","unstructured":"Lu X, Edwards LE, Desheva JA , et al. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1):viruses. Vaccine 2006; 24 (44-46) : 6588-93.","journal-title":"Vaccine."}],"container-title":["The Open Microbiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V8\/TOMICROJ-8-154\/TOMICROJ-8-154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V8\/TOMICROJ-8-154\/TOMICROJ-8-154.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V8\/TOMICROJ-8-154\/TOMICROJ-8-154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T10:38:12Z","timestamp":1598697492000},"score":1,"resource":{"primary":{"URL":"https:\/\/openmicrobiologyjournal.com\/VOLUME\/8\/PAGE\/154\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12,31]]}},"alternative-id":["TOMICROJ-8-154"],"URL":"https:\/\/doi.org\/10.2174\/1874285801408010154","relation":{},"ISSN":["1874-2858"],"issn-type":[{"value":"1874-2858","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2014-7-3","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-9-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-2","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}